comparing different dosing strategies and wide variation in physician and patient preferences regarding the tradeoff between the increased efficacy and risks of toxicity associated with higher starting doses. This recommendation refers only to the initial prescribing of methotrexate and is not meant to limit further dose escalation, which often provides additional efficacy A split dose of oral methotrexate over 24 hours or weekly subcutaneous injections, and/or an increased dose of